Fast and accurate in silico antigen typing with Kaptive 3
Top Cited Papers
Open Access
- 24 June 2025
- journal article
- Published by Microbiology Society in Microbial Genomics
- Vol. 11 (6) , 001428
Abstract
Surface polysaccharides are common antigens in priority pathogens and therefore attractive targets for novel control strategies such as vaccines, monoclonal antibody and phage therapies. Distinct serotypes correspond to diverse polysaccharide structures that are encoded by distinct biosynthesis gene clusters; e.g. the Klebsiella pneumoniae species complex (KpSC) K- and O-loci encode the synthesis machinery for the capsule (K) and outer-lipopolysaccharides (O), respectively. We previously presented Kaptive and Kaptive 2, programmes to identify K- and O-loci directly from KpSC genome assemblies (later adapted for Acinetobacter baumannii), enabling sero-epidemiological analyses to guide vaccine and phage therapy development. However, for some KpSC genome collections, Kaptive (v≤2) was unable to type a high proportion of K-loci. Here, we identify the cause of this issue as assembly fragmentation and present a new version of Kaptive (v3) to circumvent this problem, reduce processing times and simplify output interpretation. We compared the performance of Kaptive v2 and Kaptive v3 for typing genome assemblies generated from subsampled Illumina read sets (decrements of 10× depth), for which a corresponding high-quality completed genome was also available to determine the ‘true’ loci (n=549 KpSC, n=198 A. baumannii). Both versions of Kaptive showed high rates of agreement to the matched true locus amongst ‘typeable’ locus calls (≥96% for ≥20× read depth), but Kaptive v3 was more sensitive, particularly for low-depth assemblies (at 1 order of magnitude faster than Kaptive v2, making it easy to analyse thousands of assemblies on a desktop computer, facilitating broadly accessible in silico serotyping that is both accurate and sensitive. The Kaptive v3 source code is freely available on GitHub (https://github.com/klebgenomics/Kaptive), and has been implemented in Kaptive Web (https://kaptive-web.erc.monash.edu/).Keywords
All Related Versions
Funding Information
- National Health and Medical Research Council (APP1176192)
- Bill and Melinda Gates Foundation (INV049641)
This publication has 48 references indexed in Scilit:
- Identifying WHO global priority endemic pathogens for vaccine research and development (R&D) using multi-criteria decision analysis (MCDA): an objective of the Immunization Agenda 2030EBioMedicine, 2024
- Population genomics uncovers global distribution, antimicrobial resistance, and virulence genes of the opportunistic pathogen Klebsiella aerogenesCell Reports, 2024
- Vaccine value profile for Klebsiella pneumoniaeVaccine, 2024
- Bacterial capsules: Occurrence, mechanism, and functionnpj Biofilms and Microbiomes, 2024
- Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countriesNature Microbiology, 2021
- The role of vaccines in combatting antimicrobial resistanceNature Reviews Microbiology, 2021
- Diversity and evolution of surface polysaccharide synthesis loci in EnterobacterialesThe ISME Journal, 2020
- Recent advances in the production of recombinant glycoconjugate vaccinesnpj Vaccines, 2019
- MMseqs2 enables sensitive protein sequence searching for the analysis of massive data setsNature Biotechnology, 2017
- Identification of common molecular subsequencesJournal of Molecular Biology, 1981